Safelist CRN—be sure you're getting the information you need

Catch up on dietary supplement industry and association news via our member newsletter, publishing weekly on Thursdays. And be sure to connect with CRN on LinkedIn and Twitter.

Access Daily Supplement archives here.

SEPTEMBER 21, 2023

Reflecting on our founding values and DSHEA modernization / Petition to FTC on substantiation guidance / And more

SEPTEMBER 14, 2023

Supplementation in the Dietary Guidelines / Understanding today’s supplement consumer / Connect with CRN at Expo East


Last chance to book at best rates for CRN events—don't miss CEO session with Pharmavite's Jeff Boutelle and other industry leaders / And more

AUGUST 31, 2023

Book now—conference room block closes tomorrow / Senators seek details on FDA reorg proposal / Preorder new CRN Consumer Survey for best value / And more

AUGUST 24, 2023

Catch up on a busy August in Washington / FDA Commissioner to speak during 'Now New Next' / Building brands that resonate with consumers / And more

AUGUST 22–23, 2023

INTERIM ALERT: JAMA Cardiology article on ‘Health Claims and Doses of Fish Oil Supplements in the U.S.’

AUGUST 18, 2023

INTERIM ALERT: FDA Is Failing Consumers on CBD

AUGUST 17, 2023

FDA master file guidance lacks enforcement protocols / Get to know a visionary CEO / Media mentions / And more

AUGUST 10, 2023

CRN recommends delayed implementation for Health Canada’s cost recovery proposal / Join the fun at our annual conference / And more

AUGUST 3, 2023

Early-bird rates end tomorrow for 50th anniversary events / CRN provides feedback on EPA draft plastic pollution strategy/ International updates / And more

JULY 27, 2023

CBD in the spotlight / The giant weakness in the supply chain right now / Register for 50th anniversary events by Aug. 4

JULY 20, 2023

FSA/HSA legislation introduced / Profiles in leadership / 'Nothing new' revealed by JAMA letter on botanical sports supplements

JULY 13, 2023

Letter to FDA Commissioner notes concerns about proposed reorganization / Mason Vitamins' Tacl appointed Retailer Relations Forum Chair / Media mentions / And more

JULY 6, 2023

INTERIM ALERT: CRN CEO Member Update on Proposed FDA Foods Program Reorg.

FTC revised endorsement guide released / Aspartame safety in question / and more

JUNE 29, 2022

TiO2 update in California / Science in Session agenda, speaker lineup / CRN in the news / and more

JUNE 22, 2023

‘Day on the Hill’ brings members face-to-face with legislators, staff / Member CROs comment on updated clinical trial guidance / And more

JUNE 15, 2023

Supplements for better brain health / Consumer Survey Advisory Committee reconvenes / CRN at IADSA World Supplement Forum / And more

JUNE 8, 2023

‘Science in Session’ publication explores gaps, opportunities in optimizing health with nutrition / CRN continues pushback on NY age restrictions at executive branch level / And more

JUNE 1, 2023

More science behind the supplements / Melatonin in focus / June calendar / And more

MAY 25, 2023

Good news about multivitamins / FDA CBD stakeholder session today / Legal claims for non-lawyers / Catch up on producer packaging responsibility / And more

MAY 23, 2023

INTERIM ALERT: FDA CBD stakeholder call Thursday, May 25, at 3 pm Eastern

MAY 18, 2023

Mister emphasizes melatonin safety / Catch up on counterfeiting / Doing better by women in the workplace as well as in nutrition policy

MAY 11, 2023

FDA Drug Preclusion Clause interpretation threatens innovation, consumer choice / Day on the Hill back in person June 21 / Melatonin Task Force reconvenes / And more

MAY 10, 2023

INTERIM ALERT: Citizen Petition calls on FDA to reconsider Drug Preclusion Clause interpretation

MAY 4, 2023

Mister talks 2023 policy priorities—drug preclusion and more / Complimentary educational opportunities for CRN members / Be part of CRN history

APRIL 27, 2023

JAMA Research Letter on melatonin gummies / CRN monitoring state packaging, age restriction legislation / BSCG reports from Partnership for Clean Competition Conference — and more

APRIL 25, 2023

INTERIM ALERT: JAMA Research Letter raises false alarm over levels of melatonin in gummies

APRIL 24, 2023

INTERIM ALERT: Embargoed—Melatonin gummies topic of JAMA Research Letter

APRIL 20, 2023

FTC penalty offense notices / Supporting Codex sustainability efforts / FSA and HSA holders want supplements covered / And more

APRIL 13, 2023

Supplements and pregnancy / WellComms to offer streaming virtual option / Case by case enforcement discretion won’t solve drug preclusion issues – And more

APRIL 6, 2023

Reaching influential RDs with science-based info on supplements / CRN committee meetings & Toxicology Workshop next week / And more

MARCH 30, 2023

FDA must prioritize supplements / CRN and members in the news / And more

MARCH 23, 2023

Engaging on sustainability solutions / Protecting supplement access in the states / And more

MARCH 16, 2023

What’s next for CBD? / State age-restriction proposals persist—CRN in Maryland today / And more

MARCH 9, 2023

Elevating supplements as essential to public health / Report from ExpoWest, Codex, and more